NASDAQ$ATXS
Astria Therapeutics Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Reported financial results for the third quarter ended September 30, 2021 and provided a corporate update.
Astria Therapeutics reported a net loss of $7.9 million for the third quarter of 2021, with cash and cash equivalents totaling $131.8 million as of September 30, 2021. The company's operating plan is funded through 2023.
- Cash and cash equivalents totaled $131.8 million as of September 30, 2021.
- Net cash used in operating activities for the three months ended September 30, 2021, was $7.7 million.
- Research and development expenses were $3.8 million for the three months ended September 30, 2021.
- Net loss per share basic and diluted was $0.61 for the three months ended September 30, 2021.
Headline financials
Revenue & EPS history
Astria · Revenue · Quarterly
$706K
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 7 quarterly earnings reports
+1.3%
Avg return
Earnings day
+1.4%
Avg return
5 days after
+0.6%
Avg return
30 days after
52%
22 / 42 earnings
Positive
+19.8%
Q4 2018
Best reaction
-11.6%
Q2 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | — | — | — | |
| Q3 2025 | +0.2% | +0.5% | +3.3% | |
| Q2 2025 | +3.0% | +1.7% | +11.7% | |
| Q1 2025 | +7.3% | +2.8% | +49.7% | |
| Q4 2024 | +11.2% | +10.8% | -30.2% | |
| Q3 2024 | -9.6% | -17.8% | -14.7% | |
| Q2 2024 | +10.9% | +18.4% | +12.1% | |
| Q1 2024 | +1.7% | -0.9% | -7.6% | |
| Q4 2023 | -7.5% | -4.1% | -19.3% | |
| Q3 2023 | -2.0% | — | — | |
| Q2 2023 | -2.0% | — | — | |
| Q1 2023 | -0.4% | — | — | |
| Q4 2022 | +2.3% | — | — | |
| Q3 2022 | +7.9% | — | — | |
| Q2 2022 | +3.3% | — | — | |
| Q1 2022 | -2.8% | — | — | |
| Q4 2021 | +2.7% | — | — | |
| Q3 2021 | +5.4% | — | — | |
| Q2 2021 | -11.6% | — | — | |
| Q1 2021 | +0.6% | — | — | |
| Q4 2020 | +11.6% | — | — | |
| Q3 2020 | -1.4% | — | — | |
| Q2 2020 | +1.5% | — | — | |
| Q1 2020 | -0.7% | — | — | |
| Q4 2019 | -5.5% | — | — | |
| Q3 2019 | -1.3% | — | — | |
| Q2 2019 | +1.1% | — | — | |
| Q1 2019 | +12.7% | — | — | |
| Q4 2018 | +19.8% | — | — | |
| Q3 2018 | -0.8% | — | — | |
| Q2 2018 | -4.5% | — | — | |
| Q1 2018 | -8.9% | — | — | |
| Q4 2017 | +2.1% | — | — | |
| Q3 2017 | +0.0% | — | — | |
| Q2 2017 | -1.2% | — | — | |
| Q1 2017 | -1.5% | — | — | |
| Q4 2016 | -11.4% | — | — | |
| Q3 2016 | +14.4% | — | — | |
| Q2 2016 | -2.7% | — | — | |
| Q1 2016 | +6.0% | — | — | |
| Q4 2015 | +6.9% | — | — | |
| Q3 2015 | -8.0% | — | — | |
| Q2 2015 | +5.0% | — | — | |
| Q1 2015 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q4 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro